Alternatives to Ambrx
Ambrx is a Biotechnology tool: clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Ambrx
- Website
Aelis Farma43BiotechnologyBordeaux, France$54.3MClinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Jazz Pharmaceuticals24BiotechnologyDublin, Ireland$265.0MGlobal biopharmaceutical company focused on oncology and neuroscience treatments.
- Website
Human Longevity63HealthTechSan Diego, United StatesGenomics and AI-driven health intelligence company focused on extending healthy human life.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
ONCOMATRYX50BiotechnologyDerio, Spain$106.8MDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
- Website HIHistoSonics47BiotechnologyMinneapolis, USA$40.0M
Developing a new histotripsy therapeutic platform for cancer treatment.
- Website
Houdini Bio42BiotechnologyCambridge, United Kingdom$1.7MEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
- Website
Virchow Medical41BiotechnologyLa Jolla, USA$4.0MAdvancing biopsy specimen stewardship and expanding access to precision oncology.
- Website
InduPro, Inc.39BiotechnologySeattle, United States$77.0MBiotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
Showing the 20 closest matches. See the rest on the Ambrx profile.
Compare Ambrx head to head
Side by side on what each one does, what it costs, and what real users report.